Overcoming obstacles in drug substance and fill finish manufacturing partnerships In a recent Outsource Pharma webinar, Steve Folio (VP of Quality & Regulatory Affairs at Argonaut Manufacturing Services) and Peter Carbone (COO
Since the 1970’s, aseptic fill-finish has undergone multiple shifts from manual, sponsor-led operations in laminar airflow cleanrooms to highly specialized, isolator-based manufacturing. In the Trailblazers
Meet Joe Mendiola – Leader for Program Management at Argonaut What’s a day in the life of overseeing Program Managers at Argonaut? “That’s part of
Meet Ivy Nguyen – Manufacturing Technical Specialist, Formulation, at Argonaut What’s a day in the life of a Manufacturing Technical Specialist in Formulation at Argonaut?
Meet Scott Goldstein – Vice President of Strategic Partnerships, Drug Product Manufacturing at Argonaut Can you describe your role at Argonaut? No two days are
Argonaut Manufacturing Services Selected to Manufacture siRNA Medicines for Potential Prion Disease Trial Argonaut to support manufacturing needs of an siRNA therapeutic for a potential
Scott Goldstein, the Vice President of Strategic Partnerships at Argonaut Manufacturing Services, caught up with Perry Rearick at Outsourced Pharma to present a webinar covering
Meet Stacy Sutton – SVP/General Manager, Life Science Division at Argonaut What’s a day in the life of a General Manager at Argonaut? “As General
Long-standing partnership strengthens as both companies target growth in IVD sector Carlsbad, CA, Jan 28, 2025 — Argonaut Manufacturing Services (“Argonaut”), a leading contract
Tips for Risk Evaluation in Pharmaceutical Fill/Finish Sourcing In this post we focus on the critical decision pharmaceutical companies face regarding their fill/finish needs: whether